Sareum Share Discussion Threads

[gekko2023] 04/8/2022 20:37

LSE just now....

RE: Make money on SareumToday 20:00

Cobalt, people have very short memories here. Your assessment of play today has been proved correct. Kudos to you.
I seem to recollect that a Chinese Pharma handed back one of our great molecules as they couldn't find a workable solution.

[criticalthinker1] 04/8/2022 19:16

Also one other point I wrote down during the Q and A was re geopolitical impact/considerations with forward progress.
They advised pretty much all was OK but also said 'much of our current work has been done in the UK'.
So anyone got any idea what current work has been undertaken abroad?
We obviously use subcontractors but who would we have been undertaking current work with outside the UK?
Potential licensees having a mooch with not too long ago updated patents in USA?
It's obviously not FLT3 as they stipulated that was on the back burner.
Still they cannot divulge what GSK have not put into the public domain!
Best regards Steadydanny
Chicken Kiev chips and beans le soir.
Bon appetit with a side helping of GSK7371802 or another side dish with a bit of AZ sprinkled about.

[criticalthinker1] 04/8/2022 18:38

Did make me giggle re the dog barking in the background ...I wonder if it was a Pekinase! :-) ...
I note a couple posters on lse also picked up on the comment Tim made re 'we cannot divulge what GSK have not put in the public domain'
If that wasn't an indication that they are privy to sensitive information...and I'm assuming ndas..then I'm glad I bought more today.
All best Steadydanny

[horridhenry] 04/8/2022 14:19

Whilst i don't believe the liar has me on ignore for 1 second, it is very convenient for him given his arrogance, to avoid answering any of my points, which are valid.

[horridhenry] 04/8/2022 13:30

no mention of anything from anyone

how wrong could the copy and paste monger be ?

He takes out "We can't mention anything that GSK have not put into the public domain"

But conveniently omits to say that they are also in regular conversation with potential licensees confirmed in the Q & A.

It would be disappointing if they were excluding GSK, if indeed they are in conversation, same as any other large Pharma.

If CRUK are speaking to GSK ref. the future then that is good enough for me, when after all they own 72.5% of 737, and will have different class negotiators to ours

Very large pinch of salt needed with anything this fellow posts

I can cope with facts, but not daily miss information

[horridhenry] 04/8/2022 10:56

nearly at my buy price

[horridhenry] 04/8/2022 10:52

I think the barking dog in the background was there on behalf of Emma.

I'll send the recording to Dr. Dolittle

Otherwise everything as expected and no obvious slip ups - so an honest meeting with no deception.

Waiting game

[criticalthinker1] 04/8/2022 10:50

We can't mention anything that GSK have not put into the public domain.......and yes I did attend the Boston conference albeit online...which was very interesting regarding future applications and black boxes...

[criticalthinker1] 04/8/2022 09:15

Hi Norma. Enjoy your posts too.Yes I am. My preferred medium is oil's. Really like the works by Matisse.

[horridhenry] 04/8/2022 08:14

extract from another posters (Krone LSE) response from GSK wrt 737

"The two additional assets are currently being evaluated by the team to determine future development plans. I doubt that we will make any public statements regarding the status of either asset, so the best way to track the progress of SRA737 – is to keep an eye on our pipeline chart; updated quarterly which you can find here . Note that if SRA737 is included within the GSK portfolio – it will require a GSK ID – ie it will change its name. So I would look out for the CHK1 at our 3Q update. The other way to track progress is via clinicaltrials.gov "

Now, there would be little point in GSK lying would there!

of course the resident pillock knows better than even GSK

[horridhenry] 04/8/2022 07:47

Thing is norm, i never at any stage said it will be handed back !! -HE IS A PROVEN LIAR.

I merely said that there is no information to suggest that they won't hand it back, and was to counter the unconnected nonsense that he spouts

It is still the case that it remains just as likely that we will get 737 back (I hope GSK keep it, but no one knows) . In that scenario i would imagine we could well be much better off with 27.5% of another deal

The bloke is an utter pillock

[silvergreyhead1] 03/8/2022 21:30

Hmmm not quite the way I read the reply. They know Sierra had them but they will be evaluated by GSK now to see IF they will have progression.It's certainly not the we have bought Sierra for MOM but really we wanted 737 really scenario that people talk about.Quite pleased they did respond to Krone and that a team will be looking at 737 so hopefully they will shift it along.

[criticalthinker1] 03/8/2022 20:34

And once again as I've said before certain posters on lse seem to bring up what I mentioned before (first)and have put forward as questions for tomorrow.
Strange? NO! Coincidence? No!
SRA737...Read my previous posts...and hey presto conversations about it being relevant the day before investor meet!
Seriously couldn't make this up.
Still better being a lone wolf than a lifeless souless Halfwit of no original discussion.
Hope peeps are joining the dots.
Not worried about responses. Just airing my observation. It's like a cloud typing on here.
I bet Henry is now discussing that maybe GSK wont hand back 737 ..and was adamant they would.
Lmfao! The guy/girl needs therapy.
Listen to him at your peril. I'm convinced he is working for another party. Haven't read his posts but see the filter working a treat.
Maybe a question the BOD tomorrow might answer has a nuance they CAN respond to as the overlords can't deny it.
Best regards Steadydanny

[silvergreyhead1] 03/8/2022 20:10

Critical have you read the response to Krone from GSK regarding 737.On LSE

[silvergreyhead1] 03/8/2022 14:34

She will be sat at Tim's right hand side!

[horridhenry] 03/8/2022 14:26

theres bound to be a couple of questions from Emma Walmsley tomorrow, she won't be able to stop herself

[silvergreyhead1] 03/8/2022 12:36

But if we were at P2 and still going it alone wouldn't the share price be a fair few multiples of what it is now. Would be upto shareholders then whether to carry on with the risk and accept dilution with the promise of big rewards later or take their money before dilution.Think most would be gone.

[silvergreyhead1] 03/8/2022 11:45

Well that's the case all the way through to passing phase 3. However according to Tim's philosophy Sareum looks to license or even sell at preclinical. Although for the first time that I remember we have money to take us through phase 1. If we ace that in Psoriasis I don't think we will exist as a company for very long after. The sad thing is this Bulletin Board with all its camaraderie and love for each other would cease to exist as well.